Elevated pregnancy-associated plasma protein A predicts myocardial dysfunction and death in severe sepsis

Annals of Clinical Biochemistry

Volumn 51, Issue 1, 2014, Pages 22-29

  Zhang, Zhaocai ^a,b   Dai, Haiwen ^b   Yu, Yihua ^b   Yang, Jidong ^b   Chen, Jin ^b   Wu, Liang ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

Biomarker; Myocardial dysfunction; Pregnancy associated plasma protein A; Prognosis; Sepsis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN I;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL DISEASE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; VERY ELDERLY;

BIOMARKER; MYOCARDIAL DYSFUNCTION; PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PROGNOSIS; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; SEPSIS;

EID: 84887844210     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213489275     Document Type: Article

References (33)

1. Price S, Anning PB, Mitchell JA, et al. Myocardial dys function in sepsis: mechanisms and therapeutic implications. Eur Heart J 1999; 20: 715-724.
2. Blanco J, Muriel-Bombin A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008; 12: R158.
3. Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32: 660-665.
4. ver Elst KM, Spapen HD, Nguyen DN, et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46: 650-657.
5. McLean AS, Huang SJ, Nalos M, et al. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003; 31: 2611-2618.
6. Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129: 1349-1366.
7. Resch ZT, Chen BK, Bale LK, et al. Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. Endocrinology 2004; 145: 1124-1129.
8. Conover CA, Harrington SC, Bale LK, et al. Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am J Physiol Heart Circ Physiol 2007; 292: H994-H1000.
9. Coskun A, Bicik Z, Duran S, et al. Pregnancy-associated plasma protein A in dialysis patients. Clin Chem Lab Med: CCLM/FESCC 2007; 45: 63-66.
10. Coskun A, Balbay O, Duran S, et al. Pregnancy-associated plasma protein-A and asthma. Adv Ther 2007; 24: 362-367.
11. Bonaca MP, Scirica BM, Sabatine MS, et al. Prospective evaluation of pregnancy-associated plasma protein-A and outcomes in patients with acute coronary syndromes. J Am Coll Cardiol 2012; 60: 332-338.
12. Cosin-Sales J, Kaski JC, Christiansen M, et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005; 26: 2093-2098.
13. Iversen KK, Teisner AS, Teisner B, et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009; 42: 828-834.
14. Sangiorgi G, Mauriello A, Bonanno E, et al. Pregnancyassociated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 2006; 47: 2201-2211.
15. Mueller T, Dieplinger B, Poelz W, et al. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study. Clin Chem 2006; 52: 1096-1103.
16. Beaudeux JL, Burc L, Imbert-Bismut F, et al. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol 2003; 23: e7-e10.
17. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
18. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
19. Geppert A, Steiner A, Delle-Karth G, et al. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intens Care Med 2003; 29: 1384-1389.
20. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
21. Jones AE, Trzeciak S and Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009; 37: 1649-1654.
22. Zhang ZC, Dai HW, Yu YH, et al. Usefulness of hearttype fatty acid-binding protein in patients with severe sepsis. J Crit Care 2012; 27: 415.e13-415.e18.
23. Turner KL, Moore LJ, Todd SR, et al. Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide. J Am Coll Surg 2011; 213: 139-146.
24. Fernandes CJ Jr, Akamine N and Knobel E. Myocardial depression in sepsis. Shock 2008; 30(Suppl 1): 14-71.
25. Annane D, Bellissant E and Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
26. Riedemann NC, Guo RF and Ward PA. The enigma of sepsis. J Clin Invest 2003; 112: 460-467.
27. McLean AS, Huang SJ and Salter M. Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient. Crit Care 2008; 12: 215.
28. Ammann P, Fehr T, Minder EI, et al. Elevation of troponin I in sepsis and septic shock. Intens Care Med 2001; 27: 965-969.
29. Funayama A, Shishido T, Netsu S, et al. Serum pregnancy-associated plasma protein a in patients with heart failure. J Card Fail 2011; 17: 819-826.
30. Consuegra-Sanchez L, Fredericks S and Kaski JC. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 2009; 203: 346-352.
31. Schaub N, Reichlin T, Meune C, et al. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2012; 58: 246-256.
32. Pellitero S, Reverter JL, Pizarro E, et al. Pregnancy-associated plasma protein-a levels are related to glycemic control but not to lipid profile or hemostatic parameters in type 2 diabetes. Diabetes Care 2007; 30: 3083-3085.
33. Wittfooth S, Tertti R, Lepantalo M, et al. Studies on the effects of heparin products on pregnancy-associated plasma protein A. Clin Chim Acta 2011; 412: 376-381.